医学院


 
导师代码: 21411
导师姓名: 田利民
性    别:
特    称:
职    称: 研究员
学    位: 医学博士学位
属    性: 专职
电子邮件: 1072027801@qq.com

学术经历:   1994.09—1999.06 兰州大学临床医学,获学士学位; 2002.09—2005.06 兰州大学内分泌与代谢病专业,获硕士学位; 2007.09—2010.06 山东大学内分泌与代谢病专业,获博士学位; 2011.11—2012.11 德国柏林Deutsche Gesellschaft für Internationale Zusammenarbeit(GIZ) GmbH 留学1年。

个人简介:   田利民,博士,教授,主任医师,博士研究生导师,享受国务院政府特殊津贴专家。长期从事内分泌与代谢性疾病临床、科研和教学工作。现任电子科技大学附属医院,四川省人民医院大内科主任,内分泌科主任,四川省老年医学中心主任,老年内分泌科主任。兼任国家代谢性疾病临床医学研究中心分中心主任,中国医师协会内分泌代谢科医师分会副会长,中华医学会内分泌学分会委员,中华医学会糖尿病学会委员,中华预防医学会甲状腺专委会常委,中国老年医学会内分泌学分会常委,四川省医学会糖尿病学会副主任委员,四川省医促会老年医学会主任委员等。主持国家重点研发项目课题1项,国家自然科学基金项目5项,省科技重大专项等科研项目共10余项。获省部级科技进步二等奖以上奖项5项。以第一作者或通讯作者在《Hepatology》、《Thyroid》、《JCEM》等专业期刊发表论文80余篇。

科研项目:   代表性科研项目: 1. 国家自然科学基金,肠道菌群代谢物甘氨脱氧胆酸(GDCA)调控线粒体氧化应激影响亚临床甲减认知功能的作用及机制研究,项目编号82470829,2025.1-2028.12,49万元,主持; 2. 国家自然科学基金,TSH通过cAMP/PKA/CREB上调ARRDC2促心肌肥厚的机制研究,项目编号82060152 ,2021年01月至2024年12月,33万元,主持; 3. 国家自然科学基金,TRAb对心肌肥厚的影响及其机制研究,项目编号81760144,2018年01月至2021年12月,34万元,主持; 4. 国家自然科学基金,促甲状腺激素(TSH)对心脏舒缩功能影响的研究,项目编号80360125 ,2013年12月至2017年12月,49万元,主持; 5. 国家自然科学基金,促甲状腺激素(TSH)在动脉粥样硬化中的作用及机制,项目编号81360125,2012年01月至2015年12月,53万元,主持; 6. 国家重点研发计划,糖尿病防控适宜技术及管理平台的建立和示范应用研究,项目编号2018YFC1311502 ,2018年08月至2020年12月, 290万元,主持; 7. 甘肃省重点研发计划,植物外泌体在糖尿病及其并发症治疗中的应用研究,项目编号24YFFA032,2025年1月-2027年12月,20万元,主持; 8. 甘肃肃科技重大专项,1型糖尿病管理平台和标准化分级诊疗示范应用,项目编号项目编号22ZD6FA033 ,2022年08月-2025年12月,150万元,主持。

研究成果:   代表性论著: 1. Inhibiting sEH suppresses NF-κB p65 signaling and reduces CXCL10 expression as a potential therapeutic target in HT. Journal of Clinical Endocrinology and Metabolism. 2024 Mar 13:dgae163.中科院2区Top,影响因子6.134分; 2. Structural and Functional Alterations of Hippocampal Subfields in Patients with Adult-onset Primary Hypothyroidism. Journal of Clinical Endocrinology and Metabolism. 2024 Feb 7:dgae070.中科院2区Top,影响因子6.134分; 3. Alterations in gray matter morphology and functional connectivity in adult patients with newly diagnosed, untreated hypothyroidism. Thyroid. 2023 Jul;33(7):791-803 中科院1区Top,影响因子6.506分; 4. Plasma Metabolomics Reveals Systemic Metabolic Alterations of Subclinical and Clinical Hypothyroidism. Journal of Clinical Endocrinology and Metabolism.2022 Oct 1;dgac555.中科院2区Top,影响因子6.134分; 5. A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway. Hepatology.2010 Oct;52(4):1401-9.中科院1区,影响因子10.885分; 6. Development and external validation of a machine learning model to predict diabetic nephropathy in T1DM patients in the real-world. Acta Diabetologica.2024 Nov 11.doi: 10.1007/s00592-024-02404-z; 7. Association Between Dietary Tryptophan Intake and Bone Health: A Cross Sectional Study. Calcified Tissue International. 2024Dec 14;116(1):6. doi: 10.1007/s00223-024-01329-7; 8. Prevalence and Risk Factors of Cardiovascular Autonomic Neuropathy in Individuals with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Reviews in Cardiovascular Medicine.2024 Jul 3;25(7):244.doi: 10.31083/j.rcm2507244; 9. Effect of glycemic control on cognitive function in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.SYSTEMATIC REVIEWS.2024 Jan 2;13(1):10.doi: 10.1186/s13643-023-02433-9; 10. Thyroid hormone levels in patients with bipolar disorder:a systematic review and meta-analysis. BMC Endocrine Disorders.2024 Nov 18;24(1):248; 11. Development and external validation of a machine learning model to predict diabetic nephropathy in T1DM patients in the real-world. Acta Diabetologica.2024 Nov 11.doi: 10.1007/s00592-024-02404-z; 12. AssociationBetween Dietary Tryptophan Intake and Bone Health: A Cross Sectional Study. Calcified Tissue International. 2024Dec 14;116(1):6. doi: 10.1007/s00223-024-01329-7; 13. Prevalence and Risk Factors of Cardiovascular Autonomic Neuropathy in Individuals with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Reviews in Cardiovascular Medicine.2024 Jul 3;25(7):244.doi: 10.31083/j.rcm2507244; 14. Effect of glycemic control on cognitive function in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.SYSTEMATIC REVIEWS.2024 Jan 2;13(1):10.doi: 10.1186/s13643-023-02433-9.; 15. Thyroid hormone levels in patients with bipolar disorder:a systematic review and meta-analysis. BMC Endocrine Disorders.2024 Nov 18;24(1):248; 16. FNDC5/irisin ameliorates bone loss of type 1 diabetes by suppressing endoplasmic reticulum stress-mediated ferroptosis. Journal of Orthopaedic Surgery and Research. 2024 Mar 30;19(1):205.; 17. Impaired Sensitivity to Thyroid Hormones is Associated with the Risk of Diabetic Nephropathy in Euthyroid Patients with Type 1 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2024 Feb 8:17:611-618.; 18. Effect of glycemic control on cognitive function in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Systematic Reviews. 2024 Jan 2;13(1):10.; 19. Lipidomics analysis of impaired glucose tolerance and type 2 diabetes mellitus in overweight or obese elderly adults. Endocrine Connections. 2023 Nov 15;12(12):e230212.; 20. Effect of thyroid-stimulating hormone suppression therapy on cardiac structure and function in patients with differentiated thyroid cancer after thyroidectomy: a systematic review and meta-analysis. Endocrine Practice. 2023 Nov 23:S1530-891X(23)00757-7.; 21. DAP1 regulates osteoblast autophagy via the ATG16L1-LC3 axis in Graves' disease-induced osteoporosis. Journal of Orthopaedic Surgery And Research. 2023 Sep 21;18(1):711.; 22. Long-term outcomes in lean and non-lean NAFLD patients: a systematic review and meta-analysis. Endocrine. 2023 May 30.; 23. Effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide levels: A systematic review and meta-analysis.Frontiers In Endocrinology.2023 Jan 26:14:1083171.; 24. The effectiveness and Safety of Thyroid Hormone Therapy in Patients with Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of RCTs. American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions.2022 Nov;22(6):647-656.; 25. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.Frontiers In Endocrinology.2022 Jun 9:13:899503.; 26. An Update on the Economic Burden of Type 2 Diabetes Mellitus in China. Expert Review of Pharmacoeconomics & Outcomes Research.2022, 22(4): 617-625.; 27. Reporting and Methodological Quality of Systematic Reviews of DPP-4 Inhibitors for Patients with Type 2 Diabetes Mellitus: An Evidence-Based Mapping. Acta Diabetologica.2022 Dec;59(12):1539-1549.; 28. The Effectiveness of Thyroid Hormone Replacement Therapy on Heart Failure and Low-Triiodothyronine Syndrome: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.2022 Nov;28(11):1178-1186.; 29. Decision models in type 2 diabetes mellitus: A systematic review. Acta Diabetologica. 2021; 58(11):1451-1469.; 32. The Change of Left Ventricular Function in Rats with Subclinical Hypothyroid and the Effects of Thyroxine Replacement. International Journal of Endocrinology.2018,86: 1-10.; 33. Appraisal of clinical practice guidelines on the management of hypothyroidism in pregnancy using the Appraisal of Guidelines for Research and Evaluation II instrument.Endocrine.2018,60(1): 1535-1546.; 34. Adipokine expression and endothelial function in subclinical hypothyroidism rats. Endocrine Connections.2018,7(2):295-304.; 35. Adult serum 25(OH)D3 in Gansu province, northwest China: a cross-sectional study. Asia Pac J Clin Nutr.2018,27(4):832-839.; 36. Robotic Versus Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity: a Systematic Review and Meta-Analysis.Obesity Surgery.2018, 28(11): 3691-3700.; 37. The Change of Left Ventricular Function in Rats with Subclinical Hypothyroid and the Effects of Thyroxine Replacement.International Journal of Endocrinology.2018 Mar 4:2018:8682765.; 38. Relationship between Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Outcomes: A Systematic Review. International Journal of Endocrinology.2017,10:1-15.; 39. Methodological Quality Assessment of Meta-Analyses of Hyperthyroidism Treatment. hormone and metabolic research.2017,50(1).; 科研获奖: 1. 2015年《抗氧化物质对糖尿病状态下血管及肾脏功能影响的系列研究》 获省科技进步一等奖; 2. 2013年《东乡、回、汉三民族2型糖尿病若干易感基因的研究》获省科技进步二等奖; 3. 2017年《糖尿病肝窦功能障碍介导的脂肪肝的病理机制及干预策略研究》获省科技进步二等奖; 4. 2018年《促甲状腺激素(TSH)对心血管系统的作用及机制研究》获省科技进步二等奖; 5. 2021年《2型糖尿病危险因素的系列研究》获省科技进步二等奖; 6. 2024年《认知情绪功能异常的早期诊断关键神经影像生物标记筛选及应用》获省科技进步二等奖 软件著作: 1. T1DM-智慧糖控平台,软著登字第12334359号,2023.09.30

专业研究方向:
专业名称 研究领域/方向 招生类别
100200临床医学 01内科学 博士学术学位
100200临床医学 01内科学 硕士学术学位


学院列表
01  信息与通信工程学院
02  电子科学与工程学院
03  材料与能源学院
04  机械与电气工程学院
05  光电科学与工程学院
06  自动化工程学院
07  资源与环境学院
08  计算机科学与工程学院(网络空间安全学院)
09  信息与软件工程学院(示范性软件学院)
10  航空航天学院
11  数学科学学院
12  物理学院
13  医学院
14  生命科学与技术学院
15  经济与管理学院
16  公共管理学院
17  外国语学院
18  马克思主义学院
21  基础与前沿研究院
22  通信抗干扰全国重点实验室
23  电子科学技术研究院
28  电子科技大学(深圳)高等研究院
31  集成电路科学与工程学院(示范性微电子学院)
90  智能计算研究院